HomepageBIOGY • OTCMKTS
add
Biogaia Adr Class B
Vorige slotkoers
$Â 10,00
Jaar-range
$Â 9,72 - $Â 12,09
Beurswaarde
11,73Â mld. SEK
Gem. volume
150,00
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (SEK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 303,97Â mln. | -4,32% |
Bedrijfskosten | 124,96Â mln. | 7,14% |
Netto inkomsten | 36,60Â mln. | -63,94% |
Netto winstmarge | 12,04 | -62,32% |
Winst per aandeel | — | — |
EBITDA | 103,72Â mln. | -16,66% |
Effectief belastingtarief | 22,09% | — |
Balans
Totale activa
Totale passiva
| (SEK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 1,11Â mld. | -23,26% |
Totale activa | 1,90Â mld. | -17,33% |
Totale passiva | 285,12Â mln. | -10,62% |
Totaal aandelenvermogen | 1,62 mld. | — |
Uitstaande aandelen | 101,16 mln. | — |
Koers-boekwaardeverhouding | 0,62 | — |
Rendement op activa | 12,79% | — |
Rendement op kapitaal | 15,24% | — |
Kasstroom
Nettomutatie in liquide middelen
| (SEK) | sep 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 36,60Â mln. | -63,94% |
Operationele kasstroom | 100,03Â mln. | 1,06% |
Kasstroom uit beleggingen | -2,81Â mln. | 68,53% |
Kasstroom uit financiering | 14,23Â mln. | 939,29% |
Nettomutatie in liquide middelen | 106,86Â mln. | 28,81% |
Vrije kasstroom | 74,41Â mln. | 104,18% |
Over
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Opgericht
1990
Website
Werknemers
222
